Viruses, Vol. 15, Pages 2168: Rational Design of AAV-rh74, AAV3B, and AAV8 with Limited Liver Targeting

Viruses, Vol. 15, Pages 2168: Rational Design of AAV-rh74, AAV3B, and AAV8 with Limited Liver Targeting

Viruses doi: 10.3390/v15112168

Authors: Christopher Chan Kathryn K. Harris Sergei Zolotukhin Geoffrey D. Keeler

Recombinant adeno-associated viruses (rAAVs) have become one of the leading gene therapies for treating a variety of diseases. One factor contributing to rAAVs’ success is the fact that a wide variety of tissue types can be transduced by different serotypes. However, one commonality amongst most serotypes is the high propensity for liver transduction when rAAVs are administered peripherally. One of the few exceptions is the naturally occurring clade F AAV hematopoietic stem cell 16 (AAVHSC16). AAVHSC16 represents an interesting capsid in that it shows minimal liver transduction when injected peripherally. For capsids other than AAVHSC16, targeting non-liver tissues via peripheral AAV injection represents a challenge due to the high liver transduction. Thus, there is a demand for liver-de-targeted rAAV vectors. The rational design of rAAV capsids relies on current knowledge to design improved capsids and represents one means of developing capsids with reduced liver transduction. Here, we utilized data from the AAVHSC16 capsid to rationally design four non-clade F rAAV capsids that result in reduced liver transduction following peripheral injection.